Zhejiang Hisoar Pharmaceutical Co Ltd Net Asset Momentum
Zhejiang Hisoar Pharmaceutical Co Ltd net asset momentum. Zhejiang Hisoar Pharmaceutical Co Ltd (002099) recorded a net asset momentum of -8.4% as of December 2024, with net assets of CN¥5.13 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See 002099 book value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Zhejiang Hisoar Pharmaceutical Co Ltd (2003–2024)
Net asset momentum of Zhejiang Hisoar Pharmaceutical Co Ltd from 2003 to 2024. This chart tracks Zhejiang Hisoar Pharmaceutical Co Ltd's year-over-year net asset growth across 22 annual reporting periods from 2003 to 2024. The most recent momentum reading is -8.4%, with net assets of CN¥5.13 Billion CNY as of December 2024. Check how tangible is Zhejiang Hisoar Pharmaceutical Co Ltd's equity to evaluate the tangible quality of the company's equity base.
Zhejiang Hisoar Pharmaceutical Co Ltd Net Asset Momentum by Year (2003–2024)
Zhejiang Hisoar Pharmaceutical Co Ltd net asset momentum by year from 2003 to 2024. The table below shows the complete annual net asset history for Zhejiang Hisoar Pharmaceutical Co Ltd from 2003 to 2024, covering 22 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see market value of Zhejiang Hisoar Pharmaceutical Co Ltd.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥5.13 Billion | CN¥7.46 Billion | CN¥2.32 Billion | ▼ -8.4% |
| 2023 | CN¥5.60 Billion | CN¥7.52 Billion | CN¥1.92 Billion | ▼ -8.2% |
| 2022 | CN¥6.10 Billion | CN¥8.39 Billion | CN¥2.29 Billion | ▼ -0.1% |
| 2021 | CN¥6.11 Billion | CN¥8.02 Billion | CN¥1.91 Billion | ▲ +4.5% |
| 2020 | CN¥5.85 Billion | CN¥7.18 Billion | CN¥1.33 Billion | ▲ +2.2% |
| 2019 | CN¥5.72 Billion | CN¥6.75 Billion | CN¥1.02 Billion | ▲ +6.2% |
| 2018 | CN¥5.39 Billion | CN¥7.04 Billion | CN¥1.64 Billion | ▲ +4.8% |
| 2017 | CN¥5.14 Billion | CN¥7.47 Billion | CN¥2.32 Billion | ▲ +7.8% |
| 2016 | CN¥4.77 Billion | CN¥6.91 Billion | CN¥2.14 Billion | ▲ +33.5% |
| 2015 | CN¥3.57 Billion | CN¥4.83 Billion | CN¥1.26 Billion | ▲ +12.4% |
| 2014 | CN¥3.18 Billion | CN¥4.17 Billion | CN¥988.73 Million | ▲ +402.3% |
| 2013 | CN¥632.80 Million | CN¥2.11 Billion | CN¥1.48 Billion | ▼ -14.3% |
| 2012 | CN¥738.05 Million | CN¥1.92 Billion | CN¥1.18 Billion | ▲ +0.1% |
| 2011 | CN¥736.96 Million | CN¥1.44 Billion | CN¥698.17 Million | ▲ +15.5% |
| 2010 | CN¥638.04 Million | CN¥1.14 Billion | CN¥502.28 Million | ▲ +13.6% |
| 2009 | CN¥561.79 Million | CN¥996.27 Million | CN¥434.48 Million | ▲ +2.6% |
| 2008 | CN¥547.50 Million | CN¥1.01 Billion | CN¥465.58 Million | ▲ +1.8% |
| 2007 | CN¥538.06 Million | CN¥949.75 Million | CN¥411.69 Million | ▲ +3.6% |
| 2006 | CN¥519.27 Million | CN¥921.93 Million | CN¥402.66 Million | ▲ +183.8% |
| 2005 | CN¥182.96 Million | CN¥576.72 Million | CN¥393.76 Million | ▲ +38.6% |
| 2004 | CN¥132.03 Million | CN¥387.38 Million | CN¥255.35 Million | ▲ +55.3% |
| 2003 | CN¥85.03 Million | CN¥362.38 Million | CN¥277.36 Million | — |